Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natali Shirron

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Plos One|May 5, 2011
Active suppression of early immune response in tobacco by the human pathogen Salmonella TyphimuriumNatali Shirron, Sima Yaron
FEMS Microbiology Letters|January 18, 2007
Alcohol increases hemolysis by staphylococciMoshe Korem, Yael Gov, Natali Shirron, et al.
Current Microbiology|July 29, 2008
Effect of alcohol on bacterial hemolysisNatali Shirron, Moshe Korem, Amir Shuster, et al.
Cancers|March 28, 2026
Classic Kaposi Sarcoma: Current Treatment Strategies and Emerging Therapeutic ApproachesDaniela Revenko, Natali Shirron, Reut Shainer, et al.
Cancers|December 30, 2025
The Impact of Demographic and Clinico-Pathological Characteristics on Recurrence-Free Survival in Nasopharyngeal CarcinomaMuhammad Awawda, Majd Hanna, Ahmad Awawdi, et al.
Journal of Food Protection|November 12, 2009
A comparative study assaying commonly used sanitizers for antimicrobial activity against indicator bacteria and a Salmonella Typhimurium strain on fresh produceNatali Shirron, Guy Kisluk, Yifat Zelikovich, et al.
Eclinicalmedicine|June 17, 2026
Oncofertility outcomes in early-onset patients with non-breast solid malignancies: a systematic reviewNatali Shirron, Andrea Boutros, Ithai Waldhorn, et al.
Frontiers in Plant Science|July 28, 2020
From Survival to Productivity Mode: Cytokinins Allow Avoiding the Avoidance Strategy Under Stress ConditionsAvishai Avni, Yelena Golan, Natali Shirron, et al.
Journal of Clinical Medicine|April 14, 2026
Clinical Impact of Routine HBV Screening in Oncologic Patients Prior to ChemotherapyHusam Abu Sini, Natali Shirron, Michael Litvak, et al.
JTO Clinical and Research Reports|April 22, 2026
Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World StudySameh Daher, Walid Shalata, Natali Shirron, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Plos One|May 5, 2011
Active suppression of early immune response in tobacco by the human pathogen Salmonella TyphimuriumNatali Shirron, Sima Yaron
FEMS Microbiology Letters|January 18, 2007
Alcohol increases hemolysis by staphylococciMoshe Korem, Yael Gov, Natali Shirron, et al.
Current Microbiology|July 29, 2008
Effect of alcohol on bacterial hemolysisNatali Shirron, Moshe Korem, Amir Shuster, et al.
Cancers|March 28, 2026
Classic Kaposi Sarcoma: Current Treatment Strategies and Emerging Therapeutic ApproachesDaniela Revenko, Natali Shirron, Reut Shainer, et al.
Cancers|December 30, 2025
The Impact of Demographic and Clinico-Pathological Characteristics on Recurrence-Free Survival in Nasopharyngeal CarcinomaMuhammad Awawda, Majd Hanna, Ahmad Awawdi, et al.
Journal of Food Protection|November 12, 2009
A comparative study assaying commonly used sanitizers for antimicrobial activity against indicator bacteria and a Salmonella Typhimurium strain on fresh produceNatali Shirron, Guy Kisluk, Yifat Zelikovich, et al.
Eclinicalmedicine|June 17, 2026
Oncofertility outcomes in early-onset patients with non-breast solid malignancies: a systematic reviewNatali Shirron, Andrea Boutros, Ithai Waldhorn, et al.
Frontiers in Plant Science|July 28, 2020
From Survival to Productivity Mode: Cytokinins Allow Avoiding the Avoidance Strategy Under Stress ConditionsAvishai Avni, Yelena Golan, Natali Shirron, et al.
Journal of Clinical Medicine|April 14, 2026
Clinical Impact of Routine HBV Screening in Oncologic Patients Prior to ChemotherapyHusam Abu Sini, Natali Shirron, Michael Litvak, et al.
JTO Clinical and Research Reports|April 22, 2026
Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World StudySameh Daher, Walid Shalata, Natali Shirron, et al.
Pageof 2